CVS Health reaches $484 mln opioid settlement with Florida


March 30 (Reuters) – CVS Health Corp (CVS.N) said on Wednesday it had entered into an agreement with the state of Florida to resolve claims related to prescriptions for opioid medications for $484 million to be paid over a period of 18 years.

As a result of the agreement, CVS Pharmacy will no longer be a defendant in Florida’s opioid lawsuit that is scheduled for trial in April 2022.

Register now for FREE unlimited access to Reuters.com

Reporting by Ankur Banerjee in Bengaluru; Editing by Shinjini Ganguli

Our Standards: The Thomson Reuters Trust Principles.



Source link

0 0 votes
Article Rating
Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments